We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,175.00 +7.50 (+0.15%) Dow Futures
38,287.00 +49.00 (+0.13%) Nasdaq Futures
18,209.25 +30.00 (+0.17%) Russell 2000 Futures
2,028.10 +8.30 (+0.41%) Crude Oil
85.41 -0.25 (-0.29%) Gold
2,371.00 -3.10 (-0.13%)
ICU Medical, Inc. (ICUI)
After hours:
Chart Events
Performance Outlook
| Previous Close | 100.75 |
| Open | 99.65 |
| Bid | 98.16 x 200 |
| Ask | 98.62 x 100 |
| Day's Range | 97.80 - 99.84 |
| 52 Week Range | 78.28 - 212.43 |
| Volume | |
| Avg. Volume | 254,008 |
| Market Cap | 2.393B |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.23 |
| Earnings Date | May 06, 2024 - May 10, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 136.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ICUI
Related Research
- ICU Medical, Inc.ICUI: Raising target price to $111.00ICU MEDICAL INC has an Investment Rating of HOLD; a target price of $111.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.RatingFair ValueEconomic Moat5 days agoArgus Research
Simply Wall St.Shareholders in ICU Medical (NASDAQ:ICUI) are in the red if they invested five years ago
We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly. To...
GlobeNewswireICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum
SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 2
MedTech DiveSmiths Medical recalls nearly 86,000 syringe pumps over software problem
The company fixed the issues, which are linked to one reported injury, by updating its software.
- GlobeNewswire
ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference
SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. ICU Medical’s presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m. ET). Company management will also be participating in one-on-one meetin
- Simply Wall St.
Earnings Update: ICU Medical, Inc. (NASDAQ:ICUI) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Investors in ICU Medical, Inc. ( NASDAQ:ICUI ) had a good week, as its shares rose 6.1% to close at US$109 following...
Insider MonkeyICU Medical, Inc. (NASDAQ:ICUI) Q4 2023 Earnings Call Transcript
ICU Medical, Inc. (NASDAQ:ICUI) Q4 2023 Earnings Call Transcript February 27, 2024 ICU Medical, Inc. misses on earnings expectations. Reported EPS is $-0.71031 EPS, expectations were $1.18. ICU Medical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
- Thomson Reuters StreetEvents
Q4 2023 ICU Medical Inc Earnings Call
Q4 2023 ICU Medical Inc Earnings Call
ZacksZacks.com featured highlights include ICU Medical and Ardmore Shipping
ICU Medical and Ardmore Shipping are part of the Zacks Screen of the Week article.
ZacksICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of 33.05% and 4.09%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
GuruFocus.comICU Medical Inc (ICUI) Posts Mixed Q4 Results; Provides 2024 Guidance
Revenue Sees Slight Increase While Net Loss Widens Year-Over-Year
Morningstar Rating
Rating
Fair Value
Economic Moat
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| IART Integra LifeSciences Holdings Corporation | |||
| MMSI Merit Medical Systems, Inc. | |||
| HAE Haemonetics Corporation | |||
| CNMD CONMED Corporation | |||
| OFIX Orthofix Medical Inc. |
Similar to ICUI
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| MMSI Merit Medical Systems, Inc. | |||
| ATRI Atrion Corporation | |||
| NVST Envista Holdings Corporation | |||
| XRAY DENTSPLY SIRONA Inc. | |||
| HAE Haemonetics Corporation |
Analyst Price Targets (3)
Upgrades & Downgrades
| Maintains | Keybanc: Overweight to Overweight | 2/28/2024 | |
| Initiated | Keybanc: to Overweight | 2/6/2024 | |
| Initiated | CL King: to Buy | 12/14/2023 | |
| Maintains | Keybanc: to Overweight | 5/9/2023 | |
| Downgrade | Raymond James: Outperform to Market Perform | 11/8/2022 | |
| Maintains | Raymond James: to Outperform | 8/9/2022 |
Company Profile
951 Calle Amanecer
San Clemente, CA 92673
United States
949 366 2183
https://www.icumed.com
Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 14,000
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
